Functional Neuroimaging in Psychiatry-Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know

被引:28
作者
Henderson, Theodore A. [1 ,2 ,3 ,4 ]
van Lierop, Muriel J. [4 ]
McLean, Mary [4 ]
Uszler, John Michael [4 ,5 ,6 ]
Thornton, John F. [4 ,7 ]
Siow, Yin-Hui [4 ,8 ]
Pavel, Dan G. [4 ,9 ]
Cardaci, Joe [4 ,10 ,11 ]
Cohen, Phil [4 ,12 ,13 ]
机构
[1] Synapt Space Inc, Denver, CO USA
[2] Neuroluminance Inc, Denver, CO USA
[3] Dr Theodore Henderson Inc, Denver, CO USA
[4] Int Soc Appl Neuroimaging, Denver, CO USA
[5] Providence St Johns Hlth Ctr, Nucl Med, Santa Monica, CA USA
[6] Univ Calif Los Angeles, Mol & Med Pharmacol, Los Angeles, CA USA
[7] Rossiter Thornton Associates, Toronto, ON, Canada
[8] Southlake Reg Hlth Ctr, Nucl Med, Newmarket, ON, Canada
[9] PathFinder Brain SPECT, Deerfield, IL USA
[10] Univ Notre Dame, Fremantle Sch Med, Fremantle, WA, Australia
[11] Hollywood Private Hosp, Diagnost Nucl Med, Nedlands, WA, Australia
[12] Lions Gate Hosp, Nucl Med, Vancouver, BC, Canada
[13] Univ British Columbia, Radiol, Vancouver, BC, Canada
来源
FRONTIERS IN PSYCHIATRY | 2020年 / 11卷
关键词
SPECT; single photon emission computarized tomography; positron emision tomography (PET); depression; inflammation; herpes; dementia; ADHD; TRAUMATIC BRAIN-INJURY; EMISSION COMPUTED-TOMOGRAPHY; TRANSCRANIAL MAGNETIC STIMULATION; DEFICIT HYPERACTIVITY DISORDER; POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; HYPERBARIC-OXYGEN; STREPTOCOCCAL INFECTIONS; IONIZING-RADIATION; TREATMENT RESPONSE;
D O I
10.3389/fpsyt.2020.00276
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
While early efforts in psychiatry were focused on uncovering the neurobiological basis of psychiatric symptoms, they made little progress due to limited ability to observe the living brain. Today, we know a great deal about the workings of the brain; yet, none of this neurobiological awareness has translated into the practice of psychiatry. The categorical system which dominates psychiatric diagnosis and thinking fails to match up to the real world of genetics, sophisticated psychological testing, and neuroimaging. Nevertheless, the American Psychiatric Association (APA) recently published a position paper stating that neuroimaging provided no benefit to the diagnosis and treatment of psychiatric disorders. Using the diagnosis of depression as a model, we illustrate how setting aside the unrealistic expectation of a pathognomonic "fingerprint" for categorical diagnoses, we can avoid missing the biological and, therefore, treatable contributors to psychopathology which can and are visualized using functional neuroimaging. Infection, toxicity, inflammation, gut-brain dysregulation, and traumatic brain injury can all induce psychiatric manifestations which masquerade as depression and other psychiatric disorders. We review these and provide illustrative clinical examples. We further describe situations for which single photon emission computed tomography (SPECT) and positron emission tomography (PET) functional neuroimaging already meet or exceed the criteria set forth by the APA to define a neuroimaging biomarker, including the differential diagnosis of Alzheimer's disease and other dementias, the differential diagnosis of ADHD, and the evaluation of traumatic brain injury. The limitations, both real and perceived, of SPECT and PET functional neuroimaging in the field of psychiatry are also elaborated. An important overarching concept for diagnostic imaging in all its forms, including functional neuroimaging, is that imaging allows a clinician to eliminate possibilities, narrow the differential diagnosis, and tailor the treatment plan. This progression is central to any medical diagnostic process.
引用
收藏
页数:19
相关论文
共 148 条
  • [1] Albon E, 2008, Health Technol Assess, V12, piii
  • [2] Impaired concentration due to frontal lobe damage from two distinct lesion sites
    Alexander, MP
    Stuss, DT
    Shallice, T
    Picton, TW
    Gillingham, S
    [J]. NEUROLOGY, 2005, 65 (04) : 572 - 579
  • [3] Functional Neuroimaging Distinguishes Posttraumatic Stress Disorder from Traumatic Brain Injury in Focused and Large Community Datasets
    Amen, Daniel G.
    Raji, Cyrus A.
    Willeumier, Kristen
    Taylor, Derek
    Tarzwell, Robert
    Newberg, Andrew
    Henderson, Theodore A.
    [J]. PLOS ONE, 2015, 10 (07):
  • [4] Amen Daniel G, 2013, Adv Mind Body Med, V27, P6
  • [5] American Nuclear Society, 2001, POS STAT 41 HLTH EFF
  • [6] Association A.P, 2013, Diagnostic and statistical manual of mental disorders, DOI DOI 10.1176/APPI.BOOKS.9780890425596
  • [7] Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury
    Bennett, Michael H.
    Trytko, Barbara
    Jonker, Benjamin
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (12):
  • [8] Benros ME, 2020, CURR TOP BEHAV NEURO, V44, P141, DOI 10.1007/7854_2019_93
  • [9] The heterogeneity of concentrated prescribing behavior: Theory and evidence from antipsychotics
    Berndt, Ernst R.
    Gibbons, Robert S.
    Kolotilin, Anton
    Taub, Anna Levine
    [J]. JOURNAL OF HEALTH ECONOMICS, 2015, 40 : 26 - 39
  • [10] Brain Endothelial- and Epithelial-Specific Interferon Receptor Chain 1 Drives Virus-Induced Sickness Behavior and Cognitive Impairment
    Blank, Thomas
    Detje, Claudia N.
    Spiess, Alena
    Hagemeyer, Nora
    Brendecke, Stefanie M.
    Wolfart, Jakob
    Staszewski, Ori
    Zoeller, Tanja
    Papageorgiou, Ismini
    Schneider, Justus
    Paricio-Montesinos, Ricardo
    Eisel, Ulrich L. M.
    Manahan-Vaughan, Denise
    Jansen, Stephan
    Lienenklaus, Stefan
    Lu, Bao
    Imai, Yumiko
    Mueller, Marcus
    Goelz, Susan E.
    Baker, Darren P.
    Schwaninger, Markus
    Kann, Oliver
    Heikenwalder, Mathias
    Kalinke, Ulrich
    Prinz, Marco
    [J]. IMMUNITY, 2016, 44 (04) : 901 - 912